Safety and Efficacy of PD-1/PD-L1 Inhibitors in Treatment-Naive and Chemotherapy-Refractory Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
You can't know whether a peptide intervention makes sense for you without knowing where your biomarkers currently sit: IGF-1, metabolic panel, hormone levels, inflammatory markers, and body composition trends
For arthritis and musculoskeletal pain, the data can be summarized in one sentence: There is no credible human evidence that BPC-157 works, and real risks exist due to poor-quality manufacturing and illegal distribution
Here is what three studies show: A study from December 2019 to August 2022 at Kagawa University Hospital included 24 patients
Shinohara, "The Unfolded Protein Response in Lens Epithelial Cells from Galactosemic Rat Lenses", Invest
The clearance is still slow and controlled enough to provide sustained benefits all week long